Stock listing
CGTX Stock Price, News, Filings & Events — Cognition Therapeutics, Inc.
Selected listing: CGTX · BOATS · USD · US
This page tracks Cognition Therapeutics, Inc.'s CGTX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CGTX:BOATS. CGTX:BOATS is the stock-level entry point for investors researching Cognition Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cognition Therapeutics, Inc. (CGTX) is a publicly traded company in the American market, with a market capitalization of approximately $82.3 million. The company focuses on developing therapies for neurodegenerative diseases. Its innovative approach aims to address unmet medical needs in this critical area of healthcare.
- Ticker
- CGTX:BOATS
- Asset type
- Stock
- Market cap
- $97.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Cognition Therapeutics, Inc. CGTX:BOATS stock context
This page tracks Cognition Therapeutics, Inc.'s CGTX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CGTX:BOATS. CGTX:BOATS is the stock-level entry point for investors researching Cognition Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cognition Therapeutics, Inc. (CGTX) is a publicly traded company in the American market, with a market capitalization of approximately $82.3 million. The company focuses on developing therapies for neurodegenerative diseases. Its innovative approach aims to address unmet medical needs in this critical area of healthcare.
Latest news from Cognition Therapeutics, Inc.
Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit
July 13, 2026
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting ...
June 24, 2026
Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) T...
June 16, 2026
Cognition Therapeutics Participating in Upcoming Investor Conferences
June 1, 2026
Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis
May 21, 2026
Cognition Therapeutics, Inc. earnings calls
Cognition Therapeutics, Inc. (CGTX) Q4 2025 Earnings Call
March 26, 2026 · Replay with transcript and chapters
Cognition Therapeutics, Inc. (CGTX) Q4 2024 Earnings Call
March 20, 2025 · Replay with transcript and chapters
Cognition Therapeutics, Inc. (CGTX) Q2 2024 Earnings Call
August 8, 2024 · Replay with transcript and chapters
Cognition Therapeutics, Inc. (CGTX) Q4 2023 Earnings Call
March 26, 2024 · Replay with transcript and chapters
Cognition Therapeutics, Inc. (CGTX) Q2 2023 Earnings Call
August 8, 2023 · Replay with transcript and chapters
Cognition Therapeutics, Inc. (CGTX) Q4 2022 Earnings Call
March 23, 2023 · Replay with transcript and chapters
Research Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for CGTX:BOATS.
Cognition Therapeutics, Inc. company profile
View the public company page for Cognition Therapeutics, Inc. on 6ix.
Cognition Therapeutics, Inc. news
Read company news and market updates connected to Cognition Therapeutics, Inc..
Cognition Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Cognition Therapeutics, Inc..